Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind placebo-controlled trial of 5-HTP for fatigue in inflammatory bowel disease remission
2017-005059-10Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Jun 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in inflammatory bowel disease (IBD) comparing Oxitriptan (5-HTP) with Placebo (2 arms). Started Jun 2018; status: completed.
02
Drugs
5-hydroxytryptophan
03
Conditions
inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on 2017-005059-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-005059-10.